NCT00403988View on ClinicalTrials.gov

Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (Herceptin®) in Advanced Breast Carcinoma

PHASE2TerminatedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

December 31, 2007

Conditions

Breast Neoplasms

Interventions

DRUG

Oxaliplatin

DRUG

vinorelbine

Trial Locations (1)

Unknown

AmericanUBMC, Beirut

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

American University of Beirut Medical Center

OTHER